Published in PLoS One on January 09, 2013
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. Cell Host Microbe (2016) 2.17
Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (2015) 1.76
Gut-liver axis in alcoholic liver disease. Gastroenterology (2014) 1.42
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A (2014) 1.31
The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol (2014) 1.28
Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation. PLoS One (2013) 1.16
Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol (2014) 1.06
Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res (2015) 0.95
Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors. PLoS One (2013) 0.95
Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. Alcohol Clin Exp Res (2015) 0.93
The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol (2015) 0.93
Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol (2014) 0.89
Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol Clin Exp Res (2014) 0.89
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Res (2015) 0.87
Alcoholic Liver Disease: Update on the Role of Dietary Fat. Biomolecules (2016) 0.86
Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction. Toxicol Appl Pharmacol (2015) 0.86
Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract (2015) 0.85
Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives. World J Gastroenterol (2014) 0.83
The Circadian Clock Mutation Promotes Intestinal Dysbiosis. Alcohol Clin Exp Res (2016) 0.83
Role of microRNAs in Alcohol-Induced Multi-Organ Injury. Biomolecules (2015) 0.82
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 0.82
Microbiota-based treatments in alcoholic liver disease. World J Gastroenterol (2016) 0.81
Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J (2014) 0.81
Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease. PLoS One (2015) 0.81
Dietary and Lifestyle Factors Associated with Colorectal Cancer Risk and Interactions with Microbiota: Fiber, Red or Processed Meat and Alcoholic Drinks. Gastrointest Tumors (2015) 0.80
Alcohol and the Intestine. Biomolecules (2015) 0.80
Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease. Mediators Inflamm (2014) 0.80
Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J Gastrointest Pathophysiol (2014) 0.79
Lactobacillus plantarum TWK10 Supplementation Improves Exercise Performance and Increases Muscle Mass in Mice. Nutrients (2016) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum. Clin Transl Gastroenterol (2016) 0.78
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? Gastroenterology (2016) 0.78
Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness. Redox Biol (2014) 0.78
Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. Int J Mol Sci (2014) 0.78
Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B (2015) 0.78
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol (2016) 0.78
Explaining diversity in metagenomic datasets by phylogenetic-based feature weighting. PLoS Comput Biol (2015) 0.77
Modulation of Intestinal Barrier and Bacterial Endotoxin Production Contributes to the Beneficial Effect of Nicotinic Acid on Alcohol-Induced Endotoxemia and Hepatic Inflammation in Rats. Biomolecules (2015) 0.77
Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer. Sci Rep (2016) 0.76
Alcohol induced alterations to the human fecal VOC metabolome. PLoS One (2015) 0.76
Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms. BMC Microbiol (2014) 0.76
Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice. PLoS One (2017) 0.75
The role of the gut-brain axis in alcohol use disorders. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.75
Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cell Mol Gastroenterol Hepatol (2015) 0.75
Microbiome in NAFLD and ALD. Clin Liver Dis (Hoboken) (2015) 0.75
Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. Lipids Health Dis (2017) 0.75
Gut region-dependent alterations of nitrergic myenteric neurons after chronic alcohol consumption. World J Gastrointest Pathophysiol (2015) 0.75
The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry (2017) 0.75
Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms (2015) 0.75
Gut Microbiota and Metagenomic Advancement in Digestive Disease. Gastroenterol Res Pract (2016) 0.75
Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model. Crit Care (2014) 0.75
Aflatoxin B1 Induced Compositional Changes in Gut Microbial Communities of Male F344 Rats. Toxicol Sci (2015) 0.75
Genome-Wide Analysis of Oceanimonas sp. GK1 Isolated from Gavkhouni Wetland (Iran) Demonstrates Presence of Genes for Virulence and Pathogenicity. Cell J (2015) 0.75
Lactobacillus rhamnosus GG Effect on Behavior of Zebrafish During Chronic Ethanol Exposure. Biores Open Access (2016) 0.75
Sarcopenia in alcoholic liver disease: clinical and molecular advances. Alcohol Clin Exp Res (2017) 0.75
Alcohol and Gut-Derived Inflammation. Alcohol Res (2017) 0.75
Organ-Organ Crosstalk and Alcoholic Liver Disease. Biomolecules (2017) 0.75
Prophylactic tributyrin treatment mitigates chronic-binge alcohol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol (2017) 0.75
Drunk bugs: Chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice. Behav Brain Res (2017) 0.75
Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther (2017) 0.75
Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition. Alcohol Res (2017) 0.75
A Review on the Applications of Next Generation Sequencing Technologies as Applied to Food-Related Microbiome Studies. Front Microbiol (2017) 0.75
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol (2009) 77.55
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics (2006) 25.13
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res (2011) 17.21
The RDP (Ribosomal Database Project). Nucleic Acids Res (1997) 12.94
Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol (2009) 8.06
Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One (2012) 3.49
TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol (2004) 3.12
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology (1995) 2.58
Cytokines in alcoholic liver disease. Semin Liver Dis (1999) 2.37
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol (2000) 2.36
Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol (2003) 2.33
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol (2012) 2.28
Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol (1987) 2.28
Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology (2010) 2.23
Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Bioinformatics (2011) 2.15
Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2004) 2.04
Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol (1991) 1.91
Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol (2012) 1.79
Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res (2009) 1.75
Evaluation of universal probes and primer sets for assessing total bacterial load in clinical samples: general implications and practical use in endodontic antimicrobial therapy. J Clin Microbiol (2005) 1.73
Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med (1994) 1.71
Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med (1989) 1.67
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr (2001) 1.53
Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol (2009) 1.52
Probiotics as modulators of the gut flora. Br J Nutr (2002) 1.46
Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther (2001) 1.46
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A (2008) 1.41
Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol (2011) 1.14
Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis (2004) 1.08
Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2008) 1.06
Probiotics in health maintenance and disease prevention. Altern Med Rev (2003) 1.01
Specific identification of certain probiotic Lactobacillus rhamnosus strains with PCR primers based on phage-related sequences. Int J Food Microbiol (2003) 0.98
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol (2009) 0.92
[Corynebacterium xerosis endocarditis associated with alcoholic cirrhosis]. Gastroenterol Clin Biol (1996) 0.81
The complete genome of an individual by massively parallel DNA sequencing. Nature (2008) 52.81
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
A catalog of reference genomes from the human microbiome. Science (2010) 8.10
Genome-wide survey of SNP variation uncovers the genetic structure of cattle breeds. Science (2009) 7.64
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol (2011) 7.53
Developmental plasticity and human health. Nature (2004) 7.13
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med (2007) 5.39
A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res (2004) 4.32
Mind the gap: upgrading genomes with Pacific Biosciences RS long-read sequencing technology. PLoS One (2012) 4.18
Assemblathon 2: evaluating de novo methods of genome assembly in three vertebrate species. Gigascience (2013) 4.11
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol (2007) 3.25
Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med (2011) 3.20
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol (2004) 3.04
The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse. J Bacteriol (2008) 2.97
Illumina universal bead arrays. Methods Enzymol (2006) 2.88
Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib. Mol Cancer Ther (2010) 2.78
Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol (2008) 2.71
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Complete genome sequence of Rickettsia typhi and comparison with sequences of other rickettsiae. J Bacteriol (2004) 2.44
Whole-genome genotyping. Methods Enzymol (2006) 2.16
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13
Treatment of benign prostatic hyperplasia using transurethral split of the prostate with a columnar balloon catheter. J Endourol (2014) 2.08
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res (2013) 2.02
A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 1.98
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe (2011) 1.97
Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun (2002) 1.96
Bos taurus genome assembly. BMC Genomics (2009) 1.83
Elevated CO2 induces physiological, biochemical and structural changes in leaves of Arabidopsis thaliana. New Phytol (2006) 1.80
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology (2007) 1.79
Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics (2007) 1.78
Paradoxical DNA repair and peroxide resistance gene conservation in Bacillus pumilus SAFR-032. PLoS One (2007) 1.71
Slit proteins regulate distinct aspects of retinal ganglion cell axon guidance within dorsal and ventral retina. J Neurosci (2006) 1.65
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem (2007) 1.63
Both maltose-binding protein and ATP are required for nucleotide-binding domain closure in the intact maltose ABC transporter. Proc Natl Acad Sci U S A (2008) 1.59
The genome sequence of Mannheimia haemolytica A1: insights into virulence, natural competence, and Pasteurellaceae phylogeny. J Bacteriol (2006) 1.55
Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium. PLoS One (2012) 1.54
Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2008) 1.54
Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J Clin Invest (2008) 1.53
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease. J Clin Oncol (2010) 1.53
Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS One (2010) 1.50
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr (2007) 1.49
Muscular dystrophy, anesthesia and the safety of inhalational agents revisited; again. Paediatr Anaesth (2006) 1.48
Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology (2008) 1.47
Neurons derive from the more apical daughter in asymmetric divisions in the zebrafish neural tube. Nat Neurosci (2010) 1.47
Meeting report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD). Pediatr Res (2007) 1.44
Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes (2009) 1.37
Developmental biology: Support mothers to secure future public health. Nature (2013) 1.35
The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun (2002) 1.33
Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr (2004) 1.33
Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med (2007) 1.32
Hypertensive disorders in pregnancy and intellectual abilities in the offspring in young adulthood: the Helsinki Birth Cohort Study. Ann Med (2011) 1.29
A method of calculating the second dimension retention index in comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A (2011) 1.28
Whole genome sequences of three Treponema pallidum ssp. pertenue strains: yaws and syphilis treponemes differ in less than 0.2% of the genome sequence. PLoS Negl Trop Dis (2012) 1.27
Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2006) 1.26
Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One (2010) 1.24
A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. ACS Nano (2013) 1.22
MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics. Anal Chem (2011) 1.19
Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr (2005) 1.19
Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol (2012) 1.18
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. Br J Haematol (2013) 1.17
Complete Genome Sequence of Elephant Endotheliotropic Herpesvirus 1A. Genome Announc (2013) 1.17
The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res (2011) 1.17
Why women of lower educational attainment struggle to make healthier food choices: the importance of psychological and social factors. Psychol Health (2009) 1.16
Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology (2005) 1.15
Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction. Stat Biopharm Res (2009) 1.14
Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases. J Mol Biol (2010) 1.14
Inference for marginal linear models for clustered longitudinal data with potentially informative cluster sizes. Stat Methods Med Res (2010) 1.14
Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol (2011) 1.14
Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients. Alcohol Res Health (2010) 1.13
iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data. J Chromatogr A (2011) 1.11
Monocyte activation in alcoholic liver disease. Alcohol (2002) 1.11
Spinal surgery: variations in health care costs and implications for episode-based bundled payments. Spine (Phila Pa 1976) (2014) 1.10
Good fat/bad fat. Hepatology (2007) 1.10
MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. Cancer Res (2011) 1.09